![Mark Pavao](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Pavao
Directeur/Membre du Conseil chez
COYA THERAPEUTICS, INC.
Profil
Mark H.
Pavao was the founder of R-Pharm US LLC, founded in 2014, where the titles held included President, Chief Executive Officer & Director.
Current jobs include Independent Director at Coya Therapeutics, Inc. starting in 2026, and Chief Commercial Officer at BioXcel Therapeutics, Inc. starting in 2026.
Former job includes Senior Vice President-Sales & Marketing at NitroMed, Inc.
Postes actifs de Mark Pavao
| Sociétés | Poste | Début |
|---|---|---|
| BIOXCEL THERAPEUTICS, INC. | Corporate Officer/Principal | 12/01/2026 |
| COYA THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/04/2026 |
Anciens postes connus de Mark Pavao
| Sociétés | Poste | Fin |
|---|---|---|
R-Pharm US LLC
 R-Pharm US LLC Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of medicines to treat cancer | Fondateur | - |
NitroMed, Inc.
 NitroMed, Inc. Pharmaceuticals: MajorHealth Technology Develops and supplies pharmaceuticals | Sales & Marketing | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
6
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
NitroMed, Inc.
NitroMed, Inc. Pharmaceuticals: MajorHealth Technology Develops and supplies pharmaceuticals | Health Technology |
R-Pharm US LLC
R-Pharm US LLC Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of medicines to treat cancer | Health Technology |
BioXcel Therapeutics, Inc.
 BioXcel Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops transformative medicines in neuroscience and immuno-oncology | Health Technology |
Coya Therapeutics, Inc.
 Coya Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that focuses on research and development of therapies to enhance the function of regulatory T cells | Health Technology |
Choisissez Zonebourse 
